Male Contraceptive Research

Man sitting on bed holding contraceptive pill

Project Summary

Despite the availability of a number of female contraceptives, the unintended pregnancy rate is significant. The need and demand for new male contraceptive options has grown, and various methods are in development. Resources are available to keep up on the latest information on male contraceptive development.

  • An estimated 85 million unintended pregnancies occur annually worldwide, with 50% ending in abortion and 13% in miscarriage.
  • Male and female contraceptive methods are often used inconsistently or discontinued, accounting for 33 million of the unintended pregnancies worldwide.
  • Few male contraceptive options currently exist (condoms, vasectomy, withdrawal), each with significant disadvantages.
  • With demand and acceptance of new male contraceptives growing, a number of potential options are being studied but none have yet made it to market.
  • Parsemus Foundation has a history of significant advocacy and financial support for non-hormonal male contraception, including support of the Clean Sheets pill, ultrasound, Gandarusa, and Vasalgel.

Project Topics

Men need more contraception options

Did you know that more than 85 million unintended pregnancies happen worldwide each year? With only condoms, vasectomy, and withdrawal as contraceptive options, men have limited choices to control their reproduction. Demand for a non-hormonal, highly effective contraceptive for men is increasing, with use expected to reduce the incidence of unplanned pregnancy.

The Parsemus Foundation has supported and promoted work on the Clean Sheets pill, ultrasound, Gandarusa, and other contraceptives as well as allocating most of the Foundation’s effort toward the development of Vasalgel.

Take Action

Do your homework when selecting male or female contraception to fully understand the pros and cons of each method. Keep in mind that the “failure” rate usually refers to perfect compliance with instructions, and actual experience often involves far more unintended pregnancies. If you are interested in new, non-hormonal contraception methods, consider donating to the Male Contraception Initiative or Vasalgel. You can stay abreast of new developments and clinical trials at the links below.

Reproductive Health News

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today